5-HT₆ receptor modulators: a patent update. Part 2. Diversity in heterocyclic scaffolds

Author： Ivachtchenko Alexandre V Ivanenkov Yan A Skorenko Andrey V

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.22, Iss.10, 2012-10, pp. : 1123-1168

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

5HT₆ receptor antagonists: a patent update. Part 1. Sulfonyl derivatives

By Ivachtchenko Alexandre V Ivanenkov Yan A

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 8, 2012-08 ,pp. : 917-964

Informa Healthcare

Access to resources Recommend Favorite

5-HT2C receptor modulators: a patent survey

By Lee Junwon Jung Myung Eun Lee Jinhwa

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 11, 2010-11 ,pp. : 1429-1455

Informa Healthcare

Access to resources Recommend Favorite

5-hydroxytryptamine subtype 6 receptor modulators: a patent survey

By Ivachtchenko Alexandre V Ivanenkov Yan A Tkachenko Sergey E

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 9, 2010-09 ,pp. : 1171-1196

Informa Healthcare

Access to resources Recommend Favorite

5-HT₇ receptor modulators: a medicinal chemistry survey of recent patent literature (2004 – 2009)

By Leopoldo Marcello Lacivita Enza Berardi Francesco Perrone Roberto

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 6, 2010-06 ,pp. : 739-754

Informa Healthcare

Access to resources Recommend Favorite

Serotonergic 5-HT6 Receptor Antagonists: Heterocyclic Chemistry and Potential Therapeutic Significance

Current Topics in Medicinal Chemistry, Vol. 15, Iss. 17, 2015-09 ,pp. : 1643-1662

Bentham Science Publishers

Access to resources Recommend Favorite